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Abstract 
 
 A wealth of small molecule compounds exist that may inhibit cancer or virus-
causing diseases, and a wide array of experiments must be performed to narrow down 
the hundreds of thousands of possible candidates to a few biologically relevant 
compounds that could serve as ideal drug candidates.  Microscale systems have the 
ability to duplicate benchtop screening experiments with the same fidelity at much 
smaller scales.  Microscale experiments also have the benefit of using very little 
precious reagent, giving the economic value of low volume usage. 
 In order to develop high density microscale experimental combinatorics, a new 
valve was developed that is passively closed at rest, termed Actuate-to-Open (AtO) 
valves.  Chapter 2 reports new design rules for AtO valve operation, both in single valve 
studies and in large on-chip arrays.  The AtO valves are also employed in a 
combinatorial screening chip with a reversible seal that allows for interchangeable 
sensing capabilities.  In Chapter 3, the combinatorial screening chip is integrated with a 
photonic crystal biosensor capable of screening for binding events in a label free 
fashion.  A proof-of-principle protein-antibody assay was performed to validate the 
combinatorial features of the chip.  In Chapter 4, the combinatorial chip was integrated 
with a molecular beacon patterned glass cover slip capable of detecting complimentary 
DNA fragments.  Total internal reflection fluorescence (TIRF) microscopy is used for 
read out of the chip.  Four virus-like oligomer targets with sequences corresponding to 
key fragments of the viruses HIV, HPV, Hepatitis A and Hepatitis B were tested against 
four different molecular beacons, each complementary to one of the four virus target 
oligonucleotides.  The result of this combinatorial screening chip indicated strong 
fluorescent values for the matching beacon-target pairs, with statistically insignificant 
values for non-matching targets.  This experiment not only established proof of principle 
of on-chip virus detection, it also demonstrated the high specificity of surface 
immobilized molecular beacons used in combination with TIRF. 
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Chapter 1 
Introduction 
 1.1. Background 
Biological screening is an expensive and time-consuming process that is 
currently performed in a well plate format using microliters of material that can be 
difficult to come by in quantity for some systems.  But these experiments performed at 
the benchtop scale could be repeated reliably at the microscale, using only picoliters of 
a reagent to yield the same results.  In drug discovery or virus detection, using tiny 
amount of precious synthetic precursors or patient blood sample will reduce cost and 
easier experimental processes than their macroscale counterparts. 
Downscaling an experiment often leads to reduced time and less cost.  For 
example, a 4 inch x 3 inch well plate with 96 wells can consume 300 μL per well for a 
total of ~3 mL.  These same reactions can be performed at the microfluidic scale, using 
picoliters of reagent per reaction in microfluidic devices.  Even accounting for dead 
volume located within filling ports (~4 μL), typical X inch by y Inch microfluidic chips 
achieve the same chemistry using only a thousandths of the same material in a high 
throughput configuration.  The same number of chemical reactions can be performed, 
just at smaller scales, which has the potential to save time, for example due to more 
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efficient mixing.  When experiments become prohibitively costly or time-intensive, a 
microfluidic route reduces both the effort and expense. 
The physical and chemical phenomena that occur at these surface-force 
dominated regions can also be exploited to maximum benefit within microfluidic chips.  
The low Reynolds number and high surface-to-volume ratios that occur within 
microfluidic systems can be exploited for excellent control over mass and heat transport 
phenomena.  For example, by shrinking the scale at which experimental procedures are 
 
Figure 1.1.  A schematic of a combinatorial screening technique on a well plate.  In this 
scheme, six reactants combine in a combinatorial fashion to develop nine separate and distinct 
products.  For precious reagents, reducing the volumes of the individual reactants becomes 
tantamount. 
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performed, a new level of control can be imposed on the mixing of reagents to produce 
higher yields [1-6] or finer temperature control [7-13].  These advantages have been 
explored in, for example, chemical synthesis [14-20], PCR amplification [21-28], and 
electrochemical systems [29-36]. 
In terms of screening, where large arrays of compounds are tested against 
sensors using as little material as possible per screening event, microfluidic devices can 
serve as a huge advantage to performing high fidelity experiments.  This thesis will 
cover the implementation of a new passively closed valve, termed here as Actuate-to-
Open (AtO) valves.  These valves enable highly portable, large scale high-density 
combinatorial devices that can be implemented in possible drug screening chips or virus 
screening. 
 1.2. Screening at the Microscale 
Microfluidic devices provide for excellent control of very small volumes, however 
analysis of the volumes at the sub-nanoliter scale can become exceedingly difficult.  
Traditional IR or UV/Vis techniques are not suitable, due to the very small path length 
through droplets that are typically compressed to 10 micrometers in height.  Because 
these volumes are so small, the signal to noise ratios gathered from such small volumes 
become insufficient for the detection of events such as molecular binding interactions.  
Recent advances in waveguide fabrication show some improvement in signal to noise 
ratio, but their fabrication requires intensive micromachining techniques [37-41].   
In effect, utilizing bulk measurements becomes increasingly difficult when the 
volume in question decreases to a few microliters.  While a microplate reader can 
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efficiently scan hundreds of microliter-sized wells per minute, the results from these 
experiments often focus on fluorescent proteins, such as green fluorescent protein 
(GFP) [42-47].  While not a problem for GFP due to the ease of production, when 
reagent becomes precious or fluorescent readout is not available, this type of microplate 
reader is unfortunately ineffective.  For experiments with nanoliter or sub-nanoliter 
volumes, analysis must be done using surface-based techniques that can leverage high 
signal to noise ratios while ignoring volume sizes.  This naturally leads to integration of 
surface-based biosensing techniques in a microfluidic environment. 
Due to the sheer number of possible compounds for an average inhibition 
screen, parameter space can quickly become unmanageable.  One method of variable 
simplification involves grouping similar compounds by family based on a defined 
reaction scheme, building so-called molecular libraries.  These libraries are 
subsequently screened for interactions, or binding events with proteins to determine 
potential drug candidates in inhibition screens, with analysis by colorimetric or 
fluorescent readout [48-52].  A single protein might be tested against an array of 
compounds, as not all proteins are active at the same pH or salt conditions.  These 
limitations lead toward an experimental setup that is scaled out rather than up, to cover 
the vast number of reactions on different chips in smaller wells without losing the 
accuracy observed in bench top experiments at the macroscale. 
High throughput screening (HTS) is defined as performing a vast array of 
experiments using as little reagent as possible per experiment.  One microscale 
example utilizes aqueous droplets suspended in oil that form due to the surface tension 
between both liquids [53-58].  Protein crystallization has been studied with hundreds of 
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aqueous droplets in such two-phase systems but may still only produce a few droplets 
with crystals viable for subsequent crystallography [59-63].  Other sensing techniques 
include MALDI [64-68], gas chromatography [69-72], and cytometry for microliter-scale 
systems [73-76].  Fluorescence based assays in particular have been utilized in 
screening experiments [77], detection of toxins [78-80] and cell proliferation studies [81, 
82].   
While vast in their application, these screening techniques are limited to the 
number of variables that can be examined within each experiment on a chip, particularly 
the different compounds that each droplet contains.  Single layer microfluidic chips 
depend on oil-water emulsions to produce separation from experiment to experiment.  
Although assays have been performed in thousands of droplets looking at few variables 
[82, 83], synthesizing molecular libraries on a chip is not feasible with this technique.  
Microscale chips analogous to 96-well plate experiments are few, and an elegant 
method of mixing large numbers of nanoliters droplets in a controlled way has still not 
been evaluated. 
Recent advances in click chemistry have yielded a host of relevant heterocyclic 
small molecules [18, 52, 84].  "Click chemistry" is so termed because the bimolecular 
reactions of relatively unstable reactants 'click' into place to create new heterocyclic 
small molecules capable of binding to disease related proteins.  While the final 
bimolecular reactions are easily done in water with copper catalyst, the precursor 
molecules can be quite difficult to synthesize, with poor yields [84-86]. 
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1.3. Microfluidic Approaches 
Multilayer soft lithography (MSL) is a technique developed by Quake et al. for 
rapidly fabricating sophisticated microfluidic chips with integrated valves that can be 
 
Figure 1.2. A schematic of actuate-to-close (AtC) valves fabricated using multilayer soft 
lithography (MSL).  A microchannel in a control layer is fabricated in PDMS and aligned over a 
microchannel in a thin fluid layer.  The valves are open in the rest state (open), and collapse 
shut on the application of an external pressure (closed). 
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used to control separation and mixing at the microscale [87-91].  Two different layers 
are replicated in polydimethylsiloxane (PDMS) using soft lithography: a fluidic layer 
composed of microchannels designed to house the necessary liquid reagents, and a 
control layer containing actuate-to-close (AtC) valves.  This second layer is placed on 
top of the fluid layer so fluid flow can be controlled in the underlying fluid layer (Figure 
1.2).  This multilayer microfluidic chip configuration has been demonstrated to vastly 
increase control at the microscale.  This has been employed in a wide range of 
applications, including rotary pumps [88], cell sorting [89, 92], cell culture [92, 93], and 
optofluidics [94-97].  The distinct advantages to using MSL in microfluidic chips is the 
ability to isolate portions of a microchannel and being able to control fluidic movement 
within the confines of nano- or pico- liter-sized reactors to perform experiments that 
were not feasible on the macroscale.  
Some difficulties arise when employing the technique of MSL for making actuate-
to-close valves.  For example, an irreversible seal is required between all layers of the 
chip, due to of the fact that positive pressure is used in the valves of the control layer 
and the channels of the fluid layer to capture and move fluid plugs.  Because the valves 
are passively open, the chip must be externally linked to pressure-controlled ancillaries 
for the duration of the experiment.  This is not a problem when readout is integrated into 
the chamber but can become taxing when the chip must be transported for screening. 
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Figure 1.3. A microfluidic combinatorial chip integrated to an unpatterned photonic crystal biosensor.  
This chip is capable of 8x8 reactions for a total of 64 products formed from 16 reagents. 
 
 1.4. Combinatorial Microfluidic Screening 
We have used MSL to design and study actuate-to-open (AtO) valves, valves 
that are closed in rest, that overcome many issues associated with the use of 
microfluidic chips with AtC valves.  The integration of new AtO valves allows microfluidic 
chips to be decoupled from ancillaries and thus to be freely transported post-filling, such 
as the combinatorial chip shown in Figure 1.3.  The design, fabrication, and 
characterization of these AtO valves will be described in Chapter 2.  Microfluidic chips 
based on these passively closed valves will be employed in combinatorial mixing chips 
capable of two types of on-chip screening.  A non-fluorescence based system 
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employing a photonic crystal biosensor for screening combinatorial products against 
cancer-related proteins will be discussed in Chapter 3.  Then, in Chapter 4 a 
fluorescence-based approach that is suitable for screening of viral compounds within a 
microfluidic well plate will be discussed.  Chapter 5 will summarize the results described 
in this thesis, and provide an outlook with respect to the utility of AtO valves, and 
microfluidic chips that use them, as well as applications of such chips.  
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Chapter 2 
Actuate-to-Open Valves 
2.1. Introduction   
Microfluidic devices that utilize actuate-to-close valves (AtC) have been 
implemented previously for a variety of applications including synthesis, separation, cell 
analysis and mixing [1-7].  These devices are comprised of microchannels that are 
between 150 and 500 µm wide and between 5 and 50 µm high. These devices use 
pico- to microliter volumes, and typically are operated in a continuous flow semibatch 
mode.  For very small batch processes at sub-nanoliter volumes, a high reaction density 
is desirable.  One method to achieve these high densities is to explore multilayer soft 
lithography [8].  Unfortunately, when these high density processes must be transported 
for analysis or screening, the AtC valves developed in this work must be continually 
attached and activated.  As AtC valves are passively open, they require continuous 
connection to an ancillary pressure source at all times.  Leaking issues can crop up 
using AtC valves in high-density systems, as pressurized compartments can deform, 
causing leaking of their contents into adjacent compartments, which makes the intricate 
coordination of mixing of reactant plugs very difficult.  For microfluidic devices that 
require densities on the order of 1 reaction/mm2, a different approach is needed to 
enable routing and mixing of fluid plugs.  
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Mathies et al. have explored an alternate valve design using passively closed valves 
using a flat-commercially available ductile membrane in between microchannels etched 
in glass [2, 9-12].  These valves also have the capability of switching out the PDMS 
membrane for a Teflon membrane for harsh systems or environments [13-15].  While 
these passively closed valves developed by Mathies et al. overcome some of the issues 
associated with the use of AtC valves, their specific design and the glass-based 
fabrication approach prevents the creation of microfluidic devices with a high density of 
functional components, such as arrays of compartments that can be isolated. 
In response to these inadequacies, we developed actuate-to-open (AtO) valves that 
seal passively closed at rest (Figure 2.1).  These valves are developed using the 
 
Figure 2.1.  Schematic of an (a) Actuate-to-Close (AtC) and (b) Actuate-to-Open valve comprised of a 
pneumatic control layer and a fluid layer made from polydimethylsiloxane (PDMS).  Both devices function 
as valve elements within multilayer microfluidic devices capable of fluid handling in volumes as low as 
picoliters in size. 
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multilayer soft lithography (MSL).  When mixing or metering operations are finished, 
devices using these valves can be disconnected from pneumatic control lines and 
transported without interrupting any ongoing experiment within the chip.  Because MSL 
is employed in fabrication, these AtO valves can be integrated in much higher densities 
(1/mm2) than the Mathies valves (1/cm2) [2]. 
The AtO valves remain passively closed at rest.  Upon the application of vacuum, 
the valves lift these PDMS walls up to open passageways within the device.  This 
vacuum also permeates into the fluid layer, due to the gas permeability of the fluid layer 
in the device.  The vacuum creates a pump for the fluid in the device as well as an 
activation of valves to allow the pumping of liquid into the fluid channels.  The overlap of 
the valves also leads to a tighter fit within the design.  Because a separate area for 
valves and a separate area for liquid storage as in AtC systems is no longer needed, 
these AtO valves can achieve higher reaction densities.  
These new valves open up new and exciting opportunities for on-chip combinatorial 
screening. Since the valves are closed in rest, these microfluidic chips can be 
decoupled from pneumatic pressure lines and transported mid-experiment without 
having to fear unwanted mixing of reactants or leakage from the device.  Chapters 3 
and 4 discuss the implementation of a 4 x 4 combinatorial screening device that 
employs the AtO valves, which can be decoupled from pressure sources for protein 
binding and virus identification, respectively.  Other applications could benefit from this 
AtO valve, but deeper understanding of the factors that determine valve operation is 
required to guide their implementation into future chips [1, 16, 17].  This chapter looks at 
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variables that influence the operational parameters of the AtO valves, including 
microchannel width, membrane thickness, and microchannel geometry, to yield a set of 
design rules to guide the development of AtO-valve based microfluidic devices. 
2.2. Results and Discussion   
2.2.1 Design and Fabrication 
Actuate-to-open valves are passively closed and are typically quite robust in 
operation, relying on a few physical principles that can influence the required pressure 
difference to open the valves.  The valves are comprised of two layers of PDMS, which 
are permanently sealed together using the partial curing technique discussed in other 
work [1].  The valves are actuated pneumatically using a vacuum line connected to a 
scaffold, with tubes connected for the pressure inlets into the device. 
In addition to pneumatic AtO valves, we also explored similar valve geometries that 
can be actuated electrostatically (Figure 2.2).  Electrostatic actuation has the advantage 
Figure 2.2. A schematic of electrostatic valve assembly.  Both layers are prepared using PDMS on 
a silicon/photoresist substrate as per standard multilayer soft lithography fabrication.  Nanotubes 
are stamped using a PDMS stamp to cover valves.  PDMS layers are then cut out, aligned and 
permanently baked together to create a permanent seal between the layers.  Electrodes are 
connected to the nanotube-based electrodes.  Applying a potential difference between the two 
parallel electrodes will create the electrical force needed to open the valve.  Typical PDMS layer 
and nanotube electrode thickness is 35 µm and 5 µm, respectively.   
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of not requiring an external pressure source, requiring smaller ancillary systems that 
vary the voltage.  Electrostatic valves have been explored in the literature at centimeter 
to decimeter scale, but few have achieved dimensions of the AtO valves studied here at 
the micrometer to millimeter scale [18-20].  Valve operation could be performed at 170V 
for a 35 µm high microchannel, the first such observation for these AtO valves.  This is 
much higher than desired for microchemical systems and further work needs to be 
performed to lower the required actuation voltage.  Because these valves rely on 
capacitative forces between oppositely charged layers of nanotubes, reducing the 
distance in between the electrodes is important for reducing the voltage required to 
actuate.  However, as the control valve is placed between the two electrodes, if the 
space between these electrodes is too small, the valve will collapse and will not 
function.  For future work, these opposing variables will need to be finely balanced in 
order to reduce the required voltage for a fully operable valve. 
Another known issue with electrostatic valve operation lies in the usage of 
nanotubes as electrodes.  First attempts at valve design included stamped nanotubes 
onto a dry surface, which was encapsulated within fully cured layers of PDMS (Figure 
2.3a,b).  The valve, filled with these dry nanotubes, became dusty and would often 
delaminate.  In order to correct for this delamination issue, an additional step was added 
for the fabrication process.  Liquid PDMS was spun on top of the nanotubes, leaving the 
nanotube layer intact while encapsulating it in a thin layer of PDMS.  By encapsulating 
the nanotube layer under a solid layer of PDMS that could be cured, individual 
nanotubes were not free to cluster and flocculate, leaving a more homogenous and 
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conductive electrode capable of holding charge (Figure 2.3c,d).   
While the electrostatic valves were interesting for pressure-free device operation, 
they were not advanced far enough to be suitable in very large scale integrated 
microfluidic devices.  For the purpose of screening applications, pressure-based AtO 
valves were optimized in this study.  In order to develop arrays of valves, deeper 
understanding is required.   Valve operation needs to be quantified as a function of 
design parameters.  For this purpose, a number of parameters were examined to 
Figure 2.3.  (a) A side view crosscut of dry encapsulated nanotube-based  AtO valve.  (b) A top view 
of a incision within a dry encapsulated nanotube-based AtO valve.  (c) A side view crosscut of a wet 
encapsulated nanotube-based AtO valve.  (d) A top view of an incision within a wet encapsulated 
nanotube-based AtO valve.  Wet encapsulation is superior to dry encapsulation, because the 
nanotubes do not flocculate nor cause delamination, as seen in left photographs.  
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discern their effect on the pressure required to open the valves. 
Fluid microchannel width, valve asymmetry and membrane thickness affect how the 
valves actuate, and how the valves return to rest.  Small changes in these variables 
were instituted in a microfluidic device using an actuate-to-open valve.  The pressure 
required to operate the valves was then recorded and averaged on three runs for each 
experiment to determine their response and how important these variables are to 
operation. 
  
 
Figure 2.4.  A schematic of the actuate-to-open (AtO) valve.  For the purposes of these studies, 
the control microchannel width is denoted by (b), the fluid microchannel height is denoted by (b), 
and the fluid microchannel height is denoted by (c).  
[© by Michael Thorson. Used with Permission.] 
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2.2.2. Operation   
Devices are prepared using multilayer soft lithography (MSL) [1], discussed in detail 
in section 2.4.  The final device is comprised of two layers of PDMS: a control layer and 
a fluid layer.  These layers are permanently sealed together using partial curing, and 
reversibly sealed to a bottom substrate, such as glass.  When the valve is at rest, the 
PDMS forms a seal based on van der Waals forces.  When the valve is allowed to relax 
back to atmospheric pressure, the thin PDMS layer demonstrates a low resistance to 
deformation and requires very little pressure to remain open.  Much of the energy spent 
in operating the valve is in the opening phase of the process overcoming van der Waals 
forces.  This hysteresis in operation is shown in Figure 2.4.  
 
Figure 2.5. A graph of the required pressure to open actuate-to-open valves.  Pressures can range from -
200 to -650 torr for valve opening, and collapse at rest when little to no pressure is applied, depending on 
fluid layer thickness.  The normalized valve actuation is defined as the amount of the PDMS inside the 
valve being lifted off the glass.  1=100% of the PDMS is lifted off the glass, where 0=no PDMS is lifted off 
of the glass. 
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This hysteresis is influenced by a number of factors, including fluid layer thickness, 
fluid microchannel width, and the geometry of the microfluidic channels, particularly the 
shape / placement of the PDMS obstruction in the microchannels that forms the valve 
(See Section 2.2.3).  For example, in a fluid layer 40 µm in height, a 75µm x 25µm 
microchannel actuates with a 250 micron-wide valve seated over it at an actuation 
pressure difference of 600 torr.  In order to operate the valves, this actuation pressure 
must overcome the van der Waals forces between PDMS and the substrate beneath it, 
which is typically glass. 
The bulk of the valve actuation energy is due to opening the valve, essentially 
ripping the valve seat off of the glass surface.  The valves close within milliseconds 
when vacuum is turned off.  PDMS has a high Young’s modulus; it stretches readily on 
the application of very little pressure.  This hysteresis of the PDMS ripping off the glass 
can be tuned with the parameters of the device that highly affect the required pressure 
for opening and closing.  Here, we will discuss how valve size, asymmetry and 
membrane thickness affect the results of the pressure required to open the valves. 
27 
 
 
Figure 2.6.  A graph of the valve response in terms of the pressure drop required to open the valve as a 
function of the fluid microchannel width.  Variations in microchannel width underneath a constant valve 
width of 250 µm lead to changes in area underneath the valve.  As the microchannel width decreases, the 
area contacted increases, and the pressure required to open the valve increases as well.  The R-squared 
value for the above correlation is 0.76. 
2.2.3. Design Rules 
In order to elucidate the behavior of the valves, a series of experiments were 
performed to determine what effect valve compartment size, valve geometry and fluid 
membrane thickness has on the required pressure drop to open the valves.  Since most 
of the pressure is converted into energy devoted to opening the valves, the pressure 
drop across the fluid membrane required to open the valves is the reported value for 
these studies.  For all valves in these studies, the valves relaxed to rest only when the 
valves were exposed to atmospheric pressure.  In all cases, the devices were prepared 
using MSL and all valves were opened fully at maximum vacuum pressure (650 torr), 
and allowed to collapse at rest for five minutes.  The pressure difference was 
0
100
200
300
400
500
600
700
800
0 100 200 300
Pr
es
su
re
 D
ro
p 
(to
rr
)
Fluid Microchannel Width (um)
28 
 
incrementally increased by adjusting valves connected to the vacuum manifold, and the 
pressure drop that was large enough to open the valves was recorded.   
2.2.3.1. Effect of Valve Size 
Quake and others have determined design rules for monolithic AtC valves using 
experimental and computational methods [2, 21].  Variations in the widths of the 
microchannels in the control and fluid layers can dramatically change the amount of 
pressure required to operate these AtC valves.  An analogous study must be performed 
in order to elucidate design rules of the AtO valving structures. 
Variations in the control channel and the fluid channel cause differences in the 
amount of applied pressure required to open AtO valves.  Other factors, including fluid 
membrane thickness and valve shape contribute to the required activating pressure as 
well.  As a channel becomes larger and larger in size, valves require less applied 
pressure to open.  A pressure drop of 200 torr was observed for most valves between 
125 and 300 µm in width.  As the channels become smaller, in the range of 50 to 125 
µm, the valves require more of a pressure drop to open.  The fluid microchannels are 
filled with atmospheric pressure, and as their widths become small, there is less area for 
this atmospheric pressure to push up against the vacuum.  Additionally, when 
comparing two control channels of equal size over two different fluid microchannels, the 
smaller fluid channel not only has less area for atmospheric pressure to push up 
against, it also has a larger area of PDMS to pull up off of the glass surface. 
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Figure 2.7.  Optical micrographs of two half-wells with AtO valves controlling flow.  (a) The valve  
within the blue oval is in a symmetrical arrangement, and it required pressures of -13 psi to activate.  
(b) The valve within the blue oval has an asymmetrical element, and required only -8 psi to open.  This 
difference is due in part to weak points introduced within the design of the fluid lines, making the 
valves require less pressure to open. 
2.2.3.2. Effect of Valve Asymmetry 
During the evolution of the combinatorial screening chip developed in Chapter 3, it 
was observed that different geometries in the shape of the fluid microchannels required 
vastly differing valve actuation pressures.  Figure 2.7 shows two sets of microfluidic 
valves with the same contact area but different relative arrangement and shape of the 
fluid channels.  The more asymmetric design could be opened with a lower vacuum. 
This effect is caused by weak points introduced within the microfluidic device, as 
observed in other studies [22, 23].  To quantify this effect, we introduced elements of 
asymmetry within the fluidic lines and studied the effect that variations in geometry 
might have on the pressure required to open the valves.   
First, a series of microchannels terminating in acute and obtuse angles was studied.  
Microchannels were fabricated as discussed previously, except they were designed to 
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be millimeters in length, to provide for generous overlap of the fluid channel with the 
valve actuation compartment.  The original overlap of the valves was utilized as a 
design feature for ease of assembly, however such generous overlap proved to be a 
source of error in data collection.  In this experiment, terminal geometry did not reveal a 
statistically significant variation in pressure response.  Further details regarding the 
experimental design revealed the extent to which the control valves overlapped the fluid 
microchannels.  In particular, a major source of error was created by creating such a 
high amount of overlap.  An observed correlation between high overlap and lower 
pressures led to the understanding that if the exposed perimeter underneath a valve 
was increased, the terminal geometry had little effect (Figure 2.8).  Valves would initially 
open from the side, rather than the terminal point, nullifying any effect those 
terminations might have as a starting point for valve opening. 
 
Figure 2.8. A schematic of how a series of valves open over time.  (left) If the valve (blue line) begins to 
lift upward (red line) closer to the perimeter of the microchannel (black line) and opens at the bottom first, 
the terminal geometry will influence at what pressure the valve will open.  (right) However, if there is 
significant overlap of 2-3 cm, the valves will lift open at the side portion of the perimeter, thus nullifying 
any effect that terminal geometry may have on the valve opening. 
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To sidestep the issues that arise from long perimeters of fluid channel, a new 
experiment was designed that limited the area of the control channel to 350 µm x 350 
µm.  Three shapes, a straight line, a diagonal line and a v-shaped gap, were used to 
determine the effect of 2 symmetry lines, 1 symmetry rotation and 1 symmetry line on 
the required activation pressure, all focused underneath these control channels.  
Adhesive studies have shown that by focusing forces onto a point (v-shaped gap), a 
noticeable drop in required lifting force is observed [24-26]. 
As observed in Figure 2.9, the introduction of asymmetry elements reduced the 
pressure required to operate the valves, in some cases by as much as 50 torr.  These 
asymmetry elements serve as focal points for the pressure forces within the fluidic 
microchannel, which reduce the overall pressure required to open the valves.  When the 
straight valve is employed, forces can be balanced on both sides of the valve equally 
 
Figure 2.9. A graph of the required pressure difference to activate valves with a straight gap (2 
lines of symmetry), a slant shape (1 rotational symmetry) and a v-shaped gap (1 line of 
symmetry with focus point).  The v-shaped gap is the easiest valve to open and requires the 
least pressure.  This is to be expected, since the atmospheric pressure within the fluid channel 
can concentrate on lifting the exposed corner of the device. 
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amongst all four sides of the rectangular shape beneath the control valve.  By creating a 
slant 45 degree angle underneath, when the fluid microchannel begins to tent under 
vacuum, the nearby obtuse angle of the microchannel perimeter is closest to the center 
of lift under the valve.  This portion of the valve is lifted first, on either side of the PDMS 
gap, and these valves require less pressure to operate due to the focusing of forces on 
these obtuse angles.  The final V-shaped valve required the least amount of pressure, 
because instead of an obtuse angle being exposed to the center of lift first, a convex 
corner was exposed first.  This focused the lift not just on a particular side first, but on 
an exposed corner, which allowed for easier lift on one side of the microchannel. 
One interesting result of this experiment is the amount of error observed for all valve 
shapes, except for the diagonal 45 degree valves.  Each set of error here is generated 
by three separate devices, so it is possible that this type of valve is the least resistant to 
misaligning in the device.  Both the straight valves and the v-shaped valves, if 
misaligned by 10-50 micrometers, would cause drastic variations in the pressure 
required to operate the valve.  The diagonal valves did not exhibit this change, because 
variations of 10-50 micrometers could be compensated by the geometry of the 
microchannels.  Because of this reliability, the diagonal 45 degree valves were utilized 
whenever possible in the combinatorial screening chips discussed in Chapters 3 and 4. 
2.2.3.3. Effect of Membrane Thickness 
The absolute thickness of the fluid layer also contributes to the operational 
parameters.  PDMS is gas permeable, so when the fluid layer becomes too thin, 
vacuum is not maintained for very long within the control layer.  Instead of atmospheric 
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or water vapor pushing up on the bottom of the device, air diffuses from the 
microchannel through the membrane into the control layer and the valve does not 
actuate. 
We studied the effect of membrane thickness on valve actuation pressures (Table 
2.1).  While no statistically significant variation was observed for thicknesses between 
27-40 µm, the thickness of 44 µm was observed to have a higher pressure requirement.  
At thicknesses lower than 27 µm, the valves would not operate up to a pressure 
difference of 650 torr, which was the full gauge pressure of the vacuum supply used for 
this experiment.  Above 44 µm, the valves would also not operate at this full vacuum 
pressure.  It is possible that two effects are simultaneously competing to reduce the 
actual pressure difference across the membrane.  The gas permeability of the PDMS 
fluid layer is a function of thickness, so it is possible that a large pressure drop cannot 
be achieved, since gas would leak from the atmospheric pressure in the fluid layer into 
the control channel.  The localized Young's modulus is also a function of fluid layer 
thickness, so it is possible that at 44 µm and above a much higher pressure is required 
for valve operation.  As a design rule, it is important to fabricate a device that does not 
succumb to either of these extremes, preferably between 27 and 40 µm in height.    
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Table 2.1. Fluid layer thicknesses varying from 10 to 59 µm were tested using 200 µm square valves over 
a 100 µm wide fluid microchannel.  Below 27 µm, the valves did not actuate due to the membrane layer 
being so thin that air passed through the layer rather than open.  Above 44 µm, the layer was too thick to 
bend properly within the small control layer size.  The local minimum and best thickness for these valves 
is 34 µm. 
2.3. Conclusions 
The power of microfluidic devices come from the ability to scale out.  Vast arrays of 
valve-based networks must be created in order to perform many analyses in parallel.  
However, further scaling out of the AtO valves discussed in this chapter is not as trivial 
as just expanding the control layer networks for valve actuation.  PDMS, the polymer 
typically used for these microfluidic devices fabricated via MSL, is very permeable to 
gas, which places limitations on the design of vast microfluidic networks.  Sustaining 
sufficient pressure drops for valve actuation across the whole chip would be difficult.  To 
that end, it is important to understand exactly how much of a pressure difference is 
required for the valves to operate reliably.  Here the pressure actuation requirements for 
valve operation as a function of fluid microchannel width, fluid layer thickness and 
microchannel geometry were studied.  Further study is needed to precisely quantify the 
pressure losses down a series of valves still will be needed.  
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In the studies reported here, variations in fluid microchannel width and microchannel 
geometry resulting in significant changes in the pressures required to actuate the valves 
(dP on the order of 200 torr).  For the most part, these results were expected.  As 
pressure is defined as force acting on a certain area, this means that a larger valve 
actuation compartment translates to a stronger force exerted on the fluid layer 
underneath.   
In early instances of valve failure, it was typically due to the design of the shape of 
the valve.  When valves could not be opened, the root cause was either a fabrication 
issue (e.g. misalignment) or a geometry issue (e.g. insufficient valve compartment area, 
too thick or too thin fluid layer).  PDMS seals tightly with many surfaces, including glass, 
due to strong van der Waals forces.  To overcome these van der Waals forces to open 
the valve requires the introduction of weak points within the valve design, such that 
lower actuation pressures suffice.  In terms of design, the valve shape that would 
require the highest actuation force would be perfectly circular in nature.  As the pressure 
drop increases across the fluid layer membrane, the force caused by this difference in 
pressure can be mitigated and balanced all throughout the circular microchannel.  This 
leads to a higher pressure difference required to lift the valve.  However, if an 
asymmetry element is introduced into the valve design , a weak point is created where 
the valve seat can start to delaminate from the glass surface.  Once a valve begins to 
open, typically the rest of the surface is easily ripped upward, as observed in other 
studies [27-29]. 
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Given the nature of the elasticity of PDMS, it was expected that alterations in fluid 
layer thickness would have had a substantial effect on valve actuation pressure, but this 
was not observed to be the case.  Variations between 27 and 44 µm did not create large 
differences in pressure requirements for the valve.  And when this range was expanded, 
valve failure was experienced in cases where the fluid layer was too thin or too thick.  
When the PDMS was too thin (<27 µm), air permeated easily through the control layer 
leading to insufficient pressure differences across the membrane.  When the layer was 
too thick (>44 µm), the PDMS layer was not easily deformable underneath the control 
channel, again causing the valve to resist from being actuated.  In summary, as a 
design rule, we determined a narrow range of membrane thicknesses that yield 
functional valves.   
After these valves were studied as to their use and the design rules that affect their 
operation, they were subsequently employed in a combinatorial design studying protein-
antibody assays (Chapter 3) and in a multiplex DNA sensing chip for virus identification 
(Chapter 4). 
2.4. Materials and Methods 
2.4.1. Device Fabrication 
For the experiments in this section, the microfluidic device is built using multilayer 
soft lithography [8].  The control layer and fluid layer designs are crafted using Freehand 
MX, with careful attention to the dimensions of the valves using the in-product ruler.  
The designs are laser printed  by the University of Illinois Print Shop (5080 dpi) onto a 
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negative transparency mask. The areas of the microchannels are clear, which allows 
UV light to pass through and harden a thin layer of SU-8 negative photoresist, spun 
onto clean silicon wafers at 2000 RPMs.  After exposure of UV light at 10.8 mW/cm2 for 
30 seconds, they are developed for one minute in PGMEA (propylene glycol 
monomethyl ether acetate).  The solvent is rinsed off using isopropyl alcohol and then 
dried under nitrogen.  The resulting silicon wafers (masters) are then surface treated for 
four hours using a silanizing agent to render them hydrophobic. 
Next PDMS (polydimethylsiloxane) is prepared in 15:1 and 5:1 ratios of 
monomer:crosslinker in total amounts of 10g and 50g each.  These materials are mixed 
vigorously and degassed using vacuum coupled to a dessicator.  The 15:1 PDMS is 
poured onto the master for the fluid layer and spun at 2000 RPMs in a spin coater, while 
the 5:1 PDMS is poured onto the master for the control layer to a thickness of ~2 mm.  
Both layers are cured at 65°C for 35 minutes, and then the control layer is cut out and 
holes are punched to provide inlets for the valves in the control layer.  The control layer 
is then aligned to the fluid layer, and the assembled device is placed in the 65°C oven 
for 1 hour to complete the irreversible seal between the layers. 
The device is then cut out from the remaining fluid layer and placed onto a substrate, 
typically a glass slide, cleaned with acetone and isopropanol prior to use.  For the 
measurements above, all valves are actuated fully and lifted off of the glass surface, 
allowed to relax back to rest and then measurements are begun immediately to avoid 
polymer chains in the PDMS reorganizing to create a very strong seal with the glass 
over time. 
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2.4.2. Pressure Readings 
For all studies performed in this chapter, the microfluidic devices were prepared 
according to the above protocol, and allowed one day to fully cure at room temperature.  
The device was then pulled off of the glass surface and placed onto a cleaned glass 
slide.  A vacuum source was hooked up to a scaffold through a ball valve and a 
pressure gauge, which was then hooked up to the microfluidic device using 
polypropylene tubing and metal tubes as shown in schematic (Figure 2.10). 
 
Figure 2.10.  A schematic of the connections and valves for the design rule experiments.  A vacuum 
source (maximum pressure 650 torr) was fed into a needle valve through Nalgene PVC tubing, which 
entered a three-way teflon valve connected to a pressure gauge.  The line continued through Nalgene 
PVC tubing to a scaffold, where the connection fed through seven three-way valves that could be 
independently operated to control valves in a microfluidic device.  At the end of the scaffold, a ball valve 
was used as an atmospheric inlet to collapse valves to rest as well as balance the pressure in a steady 
state fashion. 
To begin the experiment, the valves were connected to full vacuum (ball valve 
closed, needle valve fully opened, scaffold 3-way valves open).  This forced all valves to 
be open, as well as serve as a crosscheck to make sure the device was fully operable.  
The valves were then allowed to collapse back to rest for 5 minutes in the fully closed 
position (needle valve fully closed, ball valve open, scaffold 3-way valves fully open).  
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The 3-way valves of the scaffold were then closed, and the ball and needle valves were 
adjusted to achieve a steady pressure reading on the pressure gauge.  The 3-way 
valves leading to the microfluidic device would then be opened and the valve operation 
would be recorded.  The 3-way valve was then turned to open to atmospheric pressure 
to allow the valves to close back to rest state.  If the valve opened within 3 seconds of 
exposure to vacuum, this pressure was considered the operating pressure and this 
value was subtracted from the atmospheric pressure for that day.  This resulted as the 
pressure difference recorded in the graphs and table in this chapter. 
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Chapter 3 
Combinatorial Screening Chip Using Photonic 
Crystal Biosensors 
3.1. Introduction   
The first step in drug discovery is identifying a protein candidate that plays a key role 
in biological pathways that are believed to be involved in a disease.  After such a key 
protein has been identified and its function in certain biological pathway is understood, 
screening for small molecules that could bind to the protein and thereby possibly inhibit 
its function can commence.  New understanding has shown a variety of effects that the 
genetic code of protein has on function and interactivity [1-6].  Drug discovery involves a 
constant iterative cycle of libraries of small molecules that must be tested for their 
biological activity, which can be done computationally [7-9] and experimentally [10-14].   
The main challenge in drug discovery studies lies in the truly vast parameter space 
[15-17].  Small changes in organic structure of a molecule can lead to vastly different 
biological activity, leading to thousands of possible compounds that must be screened 
for activity.  Massive screening efforts of small molecules for their binding with target 
proteins are needed to identify potential leads for future pharmaceuticals.  The 
screening of thousands of libraries requires a huge investment in time and money.   
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This chapter will discuss a new method of combinatorial screening at picoliter scales 
using microfluidic well plates for both the synthesis and screening of a protein against a 
series of bimolecular reactions all performed on chip in concert (Figure 3.1). 
 
Figure 3.1  A photograph of an 8 x 8 microfluidic combinatorial screening chip placed on an photonic 
crystal biosensor surface.  The microfluidic device here is fabricated using MSL, with AtO valves that rely 
on a reversible seal, which allows for the sensor surface to be exchanged as necessary.   
3.2. Results and Discussion 
3.2.1. Implementation of AtO Valves 
A major benefit of the actuate-to-open valves discussed in Chapter 2 is its passively 
closed nature.  Valves in everyday life as well as in most industrial applications are 
closed most of the time.  So ideally a microfluidic device incorporates valves that are 
0.5 cm 
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closed in rest, such that no actuation is needed most of the time.   Figure 3.2 
demonstrates the filling procedure for operation of these valves.  In this 8 x 8 
microfluidic chip, one set of valves were opened, permitting flow in one direction of the 
chip (vertical).  For chip operation, reagent droplets 3 µL in volume are deposited at the 
fluid channel inlets on the surface of the chip, where they can be subsequently 
channeled into the device by the application of vacuum to the set of AtO valves 
associated with that column or row.  This method offers a way to introduce a particular 
reagent over a series of individual compartments within the chip, in each of which it will 
be combined with a different second reagent (see below), thus maximizing the 
experimental value of precious little reagent. 
 
Figure 3.2. A photograph of an 8 x 8 microfluidic screening chip demonstrating the method used to fill 
columns of 200-pl compartments. Inlets for valves, shown by tubes here in the upper left, upper right and 
lower right, are activated by vacuum for filling.  Reagents can be pipetted directly onto the inlet of each of 
the fluid channels (rows and columns), and then the fluid can be pulled into the chip by actuation of the 
AtO valves, or by applying a negative pressure at the opposite inlet.  
[Reproduced by permission of The Royal Society of Chemistry (RSC), [18]] 
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The final design of the combinatorial microfluidic chip was scaled to a 4x4 array, 
yielding 16 combinations.  The chip is configured such that a well density of 1 
reaction/mm2 was obtained  The valves were arrayed in concert, so three separate 
valves (Figure 3.2) would have control over: horizontal filling of half-wells (small black 
valves), vertical filling of half-wells (rectangular orange valves) and mixing between the 
U-shaped half-wells (square red valves).  For a given well composed of two U-shaped 
200 picoliters half-wells, these valves can be operated to fill the right side half-well using 
horizontal valves, fill the left side half-well using the vertical valves, and open the mixing 
valve between the two half-wells.  All thirty-two half wells can perform these actions in 
concert, mixing sixteen separate and different combinatorial reactions on a single 
microfluidic chip. 
 
Figure 3.3. (left) An optical micrograph of the three valves of the control channel, filled with dye.  (right) 
An optical micrograph of the fluid layer, with different dyes used to demonstrate the various rows and 
columns interconnectivity.   
[Reproduced by permission of The Royal Society of Chemistry (RSC), [18]] 
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3.2.2. Integration with Photonic Crystal Biosensor 
Analysis within the chip is performed using patterned photonic crystal biosensors, 
which have been used previously for kinetic studies of protein-substrate binding at the 
microscale [19].  These sensors, 250 µm in diameter, are centered within each U-
shaped half compartment.  Within each half-well, a biosensor can act as both a control 
and an experiment for a proof-of-principle binding experiment using a protein-antibody 
assay. 
 
Figure 3.4.  An optical micrograph of the combinatorial screening chip placed on a surface patterned 
circles of the photonic crystal biosensor.  The circular biosensors, 250 um in diameter, are patterned to 
avoid leakage between half-wells of the chip.   
[Reproduced by permission of The Royal Society of Chemistry (RSC), [18]] 
After fabrication using MSL, the bottom layer of the device is reversibly sealed to the 
patterned photonic crystal sensor surface.  Previous integration attempts of the 
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combinatorial screening chip with uniform photonic crystal biosensor surfaces 
encountered problems with respect to compartment to compartment leaking through the 
500-nanometer grooves that comprise these biosensors surfaces.  To avoid this 
leakage, the photonic crystal biosensor surface was patterned into 250 µm wide circles.  
To prepare the device for protein-based binding experiments, the entire device was built 
inside a clean room to reduce the amount of particulates that may enter the chip.  After 
fabrication and sensor integration is complete, all wells of the microfluidic chip are filled 
with phosphate buffer solution and incubated for 24 hours. 
3.2.3. On-Chip Protein/Antibody Binding Assay 
As a proof-of-principle, a protein-antibody assay was employed within the 
combinatorial screening chip to validate the fidelity of the photonic crystal biosensor and 
microfluidic control within the chip.  Protein A/G and protein A solutions were incubated 
in the right-hand half-wells of the 2nd and 4th rows, respectively.  After incubation was 
complete, all rows were rinsed and loaded with phosphate buffer solution.  In order to 
reduce nonspecific binding, both wells were coated with Sea Block agent, a salmon 
protein used to coat the exposed surfaces of the wells.  When the incubation of Sea 
Block was finished, all wells were rinsed with phosphate buffer solution.  Goat, chicken 
and human IgG antibodies were then introduced in the columns, thus entering the left 
hand wells, and a background scan was taken.  Next, the mixing valves between the 
adjacent compartments were opened and diffusive mixing was allowed to occur for 30 
minutes.  During this time IgG antibodies can interact with the protein patterned 
surfaces in the right hand wells as well as with blank control surfaces in the left hand 
wells.  At the conclusion of the 30 minute mixing time, the device was scanned again to 
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determine whether any binding occurred within each right hand half-well.  Next, earlier 
recorded background was subtracted.  As IgG antibodies bound to the surface, the 
change in the index of refraction of the material on the surface of the biosensor shifted 
in max wavelength value.  Figure 3.5 shows the scan after background subtraction.  
This data is then converted into a histogram to quantify the extent of binding interaction 
between the various protein and antibody combinations (Figure 3.6).  These results are 
expected as compared to prior work with these proteins and antibodies [20]. 
 
Figure 3.5.  The scan results of the proof-of-principle combinatorial screening chip.  Two proteins, A and 
A/G, are tested against Goat, Chicken and Human IgG antibodies.  Three rows are reserved as controls, 
filled with only phosphate buffer solution.  The binding results shown here are expected for these protein 
and antibody combinations.  
[Reproduced by permission of The Royal Society of Chemistry (RSC), [18]] 
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Figure 3.6.  A graph of the protein antibody-assay for the proof-of-principle experiment.  As expected, 
human and goat IgG adhere strongly to protein A/G, while only Human IgG adheres strongly to protein A.  
Chicken IgG does not adhere strongly to these proteins.   
[Reproduced by permission of The Royal Society of Chemistry (RSC), [18]] 
3.3. Conclusions 
The microfluidic combinatorial mixing chip described in this chapter exhibited a low 
propensity for leaking, despite using only a reversible seal between the microfluidic part 
and the sensor surface.  The successful execution of the proof-of-principle protein-
antibody experiment further demonstrated the high fidelity of the chip.  Leaking did not 
appear to interfere with chip operation and function. 
Future applications of this work would go beyond the proof-of-principle bind 
experiment described here.  For example, one can envision studying protein targets 
against libraries of small molecules that are synthesized in situ using click chemistry.  
The integration of the fine control of the combinatorial screening chip with the sensitivity 
of the photonic crystal biosensor could be further studied to determine viability in real 
world drug discovery experiment and analysis. 
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The demonstration of a combinatorial chip capable of this kind of mixing opens up 
new possibilities for performing a variety of reactions on top of a given sensor substrate.  
One such possibility, using fluorescence as a response within a microfluidic chip, is 
expounded upon in Chapter 4, with the specific purpose of virus detection.  
3.4. Materials and Methods 
3.4.1. Device Design and Assembly 
Devices were prepared in Freehand MX using multilayer soft lithography as 
discussed in previous work [21, 22].  For designing the combinatorial screening chip, 
the fluid layer was composed of a network of four horizontal channels intersecting with 
four vertical channels, each 75 µm in width.  At the end of these channels, 600 µm 
circular regions were designed to make the inlet/outlet ports.  The half-well chambers 
were composed of 250 µm circles connected to 150 µm lines forming the U-shaped 
half-wells.  All gaps for these microchannels were 40 µm in width and placed at an 
angle whenever possible to reduce the pressure required to open the valves.   
The control layer was also designed using Freehand MX.  Square valves were 
placed throughout the device to cover each gap of the fluid layer, measuring 248 µm x 
236 µm for the valves over horizontal flowing microchannels, 198 µm x 495 µm for the 
valves over the vertical flowing channels, and 292 µm x 347 µm for the mixing valves.  
These valves were connected via 49 µm microchannel runner lines to three input 
circles, 600 µm in diameter.  In order to connect the three types of valves to only three 
valve inputs, the mixing and the vertical movement valves were interdigitated across the 
chip, with the horizontal flowing valves snaking back and forth throughout the design.  
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Because the horizontal valves travel across the farthest length, these valves were the 
most susceptible to vacuum leakage and were often the first to malfunction if the chip 
showed signs of failure. 
These designs were then replicated onto a transparency mask using the laser 
printing services of the University of Illinois Print Shop (5080 dpi).  Two silicon wafers 
were first cleaned using acetone and then isopropanol, followed by drying under 
nitrogen and heated to 110°C to remove any water that might condensate onto the 
silicon wafers during drying for 10 minutes.  At the end of this drying time, the wafers 
were placed inside a spin coater.  Two milliliters of SU-8 25 were placed on the center 
of the wafer for spin coating treatment.  The program run by the spin coater ramped up 
to 2000 RPMs over 10 seconds, and then held at 2000 RPMs for 30 additional seconds.  
After this, it ramped back down to 0 RPMs in 10 seconds.  This procedure yielded a thin 
layer of photoresist, approximately25 µm in height. 
After coating, the wafer was then placed onto a hot plate preset at 65°C for 4 
minutes.  The wafer was then transferred to the second hot plate at 95°C for 8 minutes.  
The wafer was then allowed to cool for 1 minute, and then placed in a collimated UV 
light source and exposed for 20 seconds at 11 µW/cm2.  The wafer was then developed 
in PGMEA (propylene glycol methyl ether acetate) for 5 minutes, taking care to rinse 
with ispropanol.  If any white residue remained on the surface of the silicon wafer, it was 
placed back in the PGMEA and developed further.  When the silicon wafer could be 
rinsed with isopropanol and no white residue remained, the wafer was subsequently 
dried under nitrogen and stored in a petri dish.  At this point, the silicon wafers with the 
photoresist designs are to be called masters. 
52 
 
To prepare these masters for device production, they were first placed in a 
dessicator with silanizing agent for four hours.  PDMS monomer and crosslinking agents 
were mixed in a 5:1 ratio for the control layer, and a 15:1 ratio for the fluid layer.  This 
difference in crosslinker ratio allows for a tighter bond between the two layers after 
partially curing the layers separately.  The very first time a control master is used for 
device fabrication, 30 g of PDMS mixture will be required to pour into a standard size 
petri dish, which will yield a device with a thickness around 3-5 mm.  Subsequent 
devices made with the control master will only need 15 g of PDMS, due to the ring of 
unused PDMS that can be used as a placeholder from earlier device fabrication 
attempts.  For the fluid layer, only 10 g of PDMS mixture is needed.  1-2 mL of PDMS is 
poured onto the surface of a fluid layer master, which is then placed inside a spin coater 
for the same program outlined above at 2000 RPMs.  This will yield a thickness of 45 
µm PDMS for microchannels that are 25 µm in height. 
Both layers are placed inside an oven set to 65°C for 30 minutes, and are then 
checked for tackiness.  If the PDMS on the fluid layer master is solid but still sticky, the 
device can be aligned.  The control layer is cut out using a razor or scalpel, and holes 
are punched to connect to the valves in the control layer.  Given that the height of the 
control channels is only 25 µm, this pattern can be very challenging to see.  The use of 
additional and direct lighting is absolutely required, since any failed punch will destroy 
the utility of the device.  When all holes to the control layer valves have been punched, 
the fluid layer master is placed onto a vacuum-chuck mount under a microscope.  
Alignment requires careful placement of the control layer above the fluid layer, while 
making sure valves align properly to gaps in the fluid layer.  This can be done by hand, 
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or using a mechanical alignment system for careful iterative adjustment.  If only a 
certain portion of the valves are aligned, the device can be lifted at a corner, causing the 
design to be stretched or contorted to fit all valves onto the fluid layer. 
Once the valves are aligned, the device is placed into the oven at 65°C for 1 hour to 
fully cure the layers together to form an irreversible seal.  After curing, the device is cut 
from the fluid layer master using a scalpel or razor, and holes are punched to provide 
inlets for the fluid layer microchannels exposed on the bottom of the device.  If the 
device is not to be used immediately, it is placed onto a pre-cleaned glass slide to 
ensure that no dust particles adhere to the clean microchannel surface underneath. 
3.4.2. Integration to Photonic Crystal Biosensor 
The photonic crystal biosensors, developed in the laboratory of Dr. Cunningham [23, 
24], were patterned to 250 µm circles using a targeted replicated molding process 
reported by our collaborators.  The 250 µm circular sensors were patterned to match the 
design of the fluid layer of the combinatorial screening chip.  After the device is fully 
cured and all inlet ports are punched, the device is aligned to the patterned photonic 
crystal biosensor surface, aligned such that each u-shaped half-well is perfectly aligned 
to one photonic crystal sensor. 
3.4.3. Proof-of-Principle Protein-Antibody Experiment 
Phosphate buffer solution (PBS) is prepared as a pre-treatment for the combinatorial 
screening chip.  All valves of the chip are activated and the phosphate buffer solution is 
pulled into the chip using vacuum.  Because the chip will evaporate over the 24 hour 
course of treatment, the entire chip is subsequently submerged into PBS in a petri dish 
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and allowed to sit for 24 hours to fully incubate all PDMS surfaces within the chip.  Over 
the course of treatment, the chip is checked periodically to ensure that the channels do 
not dry out over time.  Because of this treatment, it is typical that the control valves are 
filled with PBS buffer as well.  This is not desirable, but can be managed with effective 
vacuum operation during the course of the experiment. 
After treatment the valves are tested the next day, ensuring small tenting within each 
control valve, which is indicative of full operation.  After valve tests, the chip can be 
subsequently used for a protein-antibody experiment. 
For all experiments outlined here, protein is prepared in PBS solution and loaded 
into fluid microchannels in horizontal rows only.  IgG antibodies, also prepared in PBS, 
are loaded into vertical channels.  Incubation times for the combinatorial experiment 
outlined in this chapter were 30 minutes, both for incubation and mixing as reported in 
previous work [18]. 
The combinatorial screening experiment used two rows incubated with protein (A 
and A/G) and two rows used as a control using PBS.  In the columns, PBS, Human IgG, 
Goat IgG and Chicken IgG were placed in the control half-well chambers (right wells).  
These antibodies within the control chambers would nonspecifically bind to the surface 
of the photonic crystal biosensor.  To determine the difference between antibodies that 
non-specifically bound to the surface of the control compartment and antibodies that 
specifically bound to the proteins patterned in the experimental compartment, a 
background scan was taken with the antibodies only in the control half-well.  After the 
mixing valve was opened and the antibodies were allowed to freely diffuse across to the 
control surface for 30 minutes, the valves were relaxed back to rest state and the 
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pressure lines were decoupled from the device.  The combinatorial device was scanned 
once more, and the peak wavelength values were background subtracted.  The 
resulting shifts in the peak wavelength corresponded to the expected binding 
parameters of the protein-antibody assay [25].  Human IgG bound strongly to the 
Protein A and Protein A/G patterned circles, and demonstrated a large shift.  Goat IgG 
bound less strongly to both proteins and demonstrated a smaller shift.  Chicken IgG, 
which should not bind to either protein, did not show an appreciable shift.  This is an 
important distinction, since the chicken IgG demonstrated a shift of non-specific binding 
when compared against an untreated surface as seen in depletion experiments.   
 
Figure 3.7. A scan of the depletion experiment performed using duplicated rows of protein A and protein 
A/G.  The protein solutions in PBS were incubated in the horizontal rows, which patterned the experiment 
PC biosensor circles on the left side.  A shift of 3.1 nm for the protein A circles indicates a large binding 
affinity, which is known for that protein.  A shift of 1.2 nm for protein A/G is also expected.  Flow 
proceeded from left to right, not showing any decrease in binding.   
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3.4.4. Depletion Experiments 
One of the unpublished results in the combinatorial screening chip experiments was 
the depletion experiments performed to ascertain the viability of the PC biosensors 
integrated with the microfluidic mold.  A major concern for microreactor studies is how 
much material is deposited onto microchannels inside the chip rather compared to the 
amount of material that actually reaches the sensor surface.  In order to quantify the 
effect of depletion, experiments were performed using duplicated protein-antibody 
experiments on chip.   
While in the published data of the previous chip, three lanes of PBS were used as 
controls to demonstrate a lack of leaking, only one such lane was used as a control for 
these depletion experiments.  Protein A was patterned in two horizontal microchannels, 
followed by Protein A/G patterned in the other two horizontal microchannels (Figure 
3.7).  These channels were staggered to ascertain whether protein upstream was being 
rinsed onto sensors downstream in the IgG loading process, given the serial nature of 
the chip.  A lack of change in color (peak wavelength) from left to right, the direction of 
flow, indicates that depletion is not a factor in these studies at the concentrations used.  
Also, since the proteins are duplicated for each set of rows, it would appear that there 
are few variations across chip. 
Subsequently, the antibodies were prepared in PBS and tested in the same way.  A 
single row was selected for control purposes, loading only with PBS (Figure 3.8).  For all 
but one half-well, the IgG showed a propensity for nonspecific binding across only the 
sensors in the right-hand wells.   
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In the case of the final half-well on this chip, it was observed that Protein A might 
have leaked within this well in the previous depletion experiment.  Subsequently, the 
chicken IgG did not show a strong shift in the upper right portion of the well.  While this 
artifact rendered this data unfit for publishing, it is important to note that on occasion the 
device will exhibit propensity for leaking.  Sometimes the cause is observable, such as a 
dust particle that adhered to the microchannels or sensor surface during fabrication.  
When a dust particle settles underneath a valve, the particle itself can force the valve to 
be continually opened and leaking can be observed.  It is extremely important for 
experimental purposes that the device be observed thoroughly, in order to avoid errors 
of this nature.  Because of this leakage in the earlier protein verification experiment, the 
shift in IgG binding was less in this particular well.  In the data published for the proof-of-
principle experiment, this issue was resolved [18]. 
 
Figure 3.8. A scan of the introduction of IgG antibodies and PBS into the combinatorial screening chip.  
This scan demonstrates a lack of depletion with flow moving from bottom to top.  Also, all sensors show 
that IgG is only patterning on the right hand side control wells.  While the non-specific binding of chicken 
IgG causes a shift of 2.7 nm as compared to just PBS, this shift is not observed when the chicken IgG 
nonspecifically binds to the protein during the full experiment. 
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3.4.5. Protein and Antibody Solutions 
Proteins used in the proof-of-principle protein-antibody assay were obtained from 
Pierce Biotechnology at stock concentrations.  Phosphate buffer solution from Sigma-
Aldrich was prepared at 0.5 mg/mL.  Sea Block from Pierce Technologies was diluted in 
PBS to 20% by volume.  The goat, chicken and human immunoglobulin G (IgG) 
antibodies were obtained from Sigma-Aldrich and prepared at a concentration of 0.5 
mg/mL in PBS.  All solutions were stored in a refrigerator at 4°C, prepared from stock 
solutions that were frozen in a -20°C freezer.   
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Chapter 4 
Total Internal Reflection Fluorescence 
Microscopy-based Combinatorial Screening 
4.1. Introduction   
The photonic crystal biosensor described in Chapter 3 is ideal for proteins or other 
large molecule (kilodalton) binding experiments.  But for smaller compounds such as 
single stranded DNA in viruses, other routes can be advantageous.  In particular, 
fluorescence microscopy is an excellent candidate to probe interactions with nucleic 
acids, facilitated by the large number of chemical alterations that can be performed with 
DNA labeled with fluorescent markers [1].  For this study, DNA hybridization is studied 
in a multiplexed fashion using the combinatorial screening chip discussed in Chapter 3.  
Because the device uses AtO valves which require a reversible seal to the bottom layer, 
a wide variety of sensors can serve as the bottom substrate of the microfluidic device.  
For virological studies of nucleic acids, molecular beacons can be used to observe 
fluorescence in the presence of the genetic material of a virus, sensing at 
concentrations lower than conventional virology methods [2].  In this work, molecular 
beacons are studied in a combinatorial screening chip for multiplex detection of viral 
targets using total internal reflection fluorescence (TIRF) microscopy.   
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Figure 4.1.  Schematic of a molecular beacon.  A fluorescent label and quencher pair are attached to 
opposite ends of a single strand of DNA.  The first and last 6-8 DNA bases are G-C rich and 
complementary, forming a stable bond.  The 20-base probe region is complementary to a DNA target 
oligonucleotide, which causes the beacon to open upon hybridiziation. 
4.1.1. Molecular Beacons 
Molecular beacons, proposed and studied by Tyagi et al., are single-stranded DNA 
probes with a self-complementary stem region occurring in the first and last 6-8 bases 
[3].  They are designed to fluoresce in the presence of a complementary single-stranded 
DNA target oligonucleotide.  In the absence of the complementary oligonucleotide, 
these molecular beacons exist in a dark state due to dye quenching [4-6].   
A fluorescent dye and quencher pair are attached at opposite ends of the 
complementary stems, which quenches fluorescence when the beacon exists in a 
hairpin conformation (Figure 4.1).  The internal 20-base section of the DNA is the probe 
region, which is complementary to a target DNA strand such as the genetic material in a 
single stranded virus.  In the presence of the viral DNA or RNA, the beacon will 
hybridize to the target oligonucleotide and change conformation to an open state, 
thereby forcing the quencher and fluorescent labels apart such that the fluorescence 
emission from the dye molecule can be detected (Figure 4.2).  The hybridization can be 
performed at room temperature or amplified in temperature ramp cycles during PCR [7]. 
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Due to the exquisite specificity of DNA base pair binding, molecular beacons are 
highly sensitive, capable of distinguishing between a perfect match and single base 
mutants [3].  As such, these beacons are ideal candidates for very sensitive detection of 
low concentration DNA such as virus genetic material that may occur in concentrations 
too low to detect by conventional means [7].  In experiments, the fluorescence signal 
detected by a camera or imaging device includes non-specific sources of fluorescence 
from ill-formed molecular beacons, foreign organic matter, and the intrinsic fluorescence 
of the material of the device, all of which increase the fluorescence background signal 
during the experiment.  In order to achieve a higher signal to noise ratio, the 
background fluorescence will need to be reduced.  In this work, a technique known as 
total internal reflection fluorescence (TIRF) microscopy enables detection in a small 
region adjacent to the surface where fluorescent markers are specifically immobilized, 
which allows for determination of target oligonucleotides containing viral genetic 
sequences.  
 
Figure 4.2.  A schematic of the molecular beacons specifically linked to a glass slide.  BSA-biotin is 
patterned onto a glass surface, followed by streptavidin.  BSA is then used to nonspecifically block any 
remaining binding sites on glass.  The biotinylated molecular beacon is incubated onto the streptavidin 
and remains in the quenched state on the surface.  In the presence of the complementary matching target 
oligonucleotide, the beacon will fluoresce on the surface. 
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4.1.2. Total Internal Reflection Fluorescence Microscopy 
Total internal reflection fluorescence (TIRF) microscopy (Figure 4.3) is used to 
generate a small fluorescence excitation volume in the vicinity of the surface, thereby 
exciting only sample materials specifically linked to the surface [8-10].  By excluding 
fluorescent material away from the surface, signal is not artificially increased from 
external factors, such as PDMS [11, 12].  TIRF microscopy differs from epifluorescence 
microscopy, where material in solution or otherwise far from the glass surface may 
contribute to the fluorescence signal, which results in high background. 
In using TIRF microscopy, the molecular beacons must be linked directly onto the 
microscope coverslip.  This chemical linkage is achieved using biotoin and streptavidin 
linkages.  DNA molecular may be purchased with a wide variety of chemical 
modifications including fluorescent labels [1, 13-16], surface chemistry linkers [17-21] 
and spacers [22-25] within the DNA chain.  The wide array of DNA modification 
chemistry that can be performed also provides for a surface-based modification of the 
molecular beacons mentioned above.  For this study, biotinylated beacons [26] were 
synthesized by Integrated DNA technologies Technologies with a fluorescent label  HEX 
(hexachlorofluoroscein) and a quencher (Iowa Black) component, with a biotin 
component located internally within the DNA along the stem [27, 28].  Molecular 
beacons are then specifically linked onto a glass coverslip using surface chemistry 
protocol discussed in Section 4.4.3. 
The main advantage in using a surface based approach is the degree of control that 
can be implemented during loading of the microchannels with molecular beacons 
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modified with various chemical functionalities.  For sensitive experimental analysis of a 
low concentration analyte, surfaces can be loaded with extremely low concentrations of 
molecular beacons down to the limit of single molecules.  Alternately, experiments may 
also be conducted with high-concentration loading of bound molecular beacons.  
Following a beacon binding to the surface, excess unbound fluorescent material is 
rinsed away with buffer.  A precisely loaded concentration of fluorescent beacons 
remains on the surface, controlled by the loading concentration buffer and the duration 
of incubation.  Overall, this protocol can be used for studies in glass-based flow cells 
and in the PDMS-based combinatorial screening chip discussed in Chapter 3. 
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Figure 4.3.  In total internal reflection fluorescence (TIRF) microscopy, the excitation beam enters the 
microscope and is directed onto the objective lens upon reflection off of the dichroic mirror.  This beam 
then impinges on the glass coverslip at an angle through immersion oil.  The beam impinges on the 
coverslip at an incident angle greater than a critical angle for total internal reflection, generating an 
evanescent wave into the medium of the sample above the glass.  As such, excitation only occurs within 
~100 nm of the region above the coverslip.  The excitation fluorescence is then collected as the beam 
passes through the dichroic mirror and is captured by a fluorescence camera.  
4.2. Results and Discussion   
4.2.1. "Bulk" Well Plate Studies of Molecular Beacons 
To establish the bulk detection sensitivity of the molecular beacons, concentration 
variation experiments were performed in 96-well optical microplates at the 50-100 µL 
Total Internal Reflection Fluorescence Microscopy 
(TIRF) - Microscopy 
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scale.  Measurements were first performed using PJAK-1 and PJAK -2 molecular 
beacons (Table 4.1) at varying concentrations in epifluorescence detection in a 
microplate reader.  Experiments were conducted both with (signal) and without 
(background) complementary target oligonucleotide present in a variety of 
concentrations.  The difference between signal and background is the signal to noise 
ratio, which will be crucial in ascertaining if the beacons are viable at extremely low 
concentrations. 
4.2.1.1. Background Fluorescence 
 
Figure 4.4. Plot of fluorescence signal from binding studies using molecular beacon PJAK-2 loaded in a 
microplate reader at volumes of 100 µL per experiment.  In each well, a final concentration of 
complementary target oligonucleotide of 0, 2 nM, 10 nM, 50 nM and 100 nM were added to the solution 
and mixed for 1 hour.  The final result shows the molecular beacon fluorescence both for the background 
(No Oligo) and in the presence of different concentrations of the target oligonucleotide.  This data 
indicated a sensitivity limit on the order of 10 nM oligomer concentration, below which the signal is 
indistinguishable from background.  
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Figure 4.4 shows the fluorescence detected in binding studies of the molecular 
beacons at concentrations between 10 nM and 500 nM for the PJAK-2 beacon mixed 
with the complementary target oligonucleotide cPJAK in concentrations between 0 and 
250 nM.  In epifluorescence measurements, the background (with no target 
oligonucleotide present) has a similar response to the 2 nM and 10 nM regimes.  
Previous work has indicated a sensitivity limit of ~2 nM for other molecular beacons in 
flow cytometry [29], which is approximated as similar to the limit observed in this work at 
the bulk concentration level.  However, the sensitivity limit is likely a function of nucleic 
acid sequence. 
Molecular beacons may show a lower sensitivity limit, particularly when coupled to 
microscopy techniques due to the amplification of signal.  A possible explanation is that 
the beacons may exhibit intermolecular interactions at higher concentrations [29].  
Beacons can self-hybridize and transition to an open conformation.  One way to 
circumvent this problem is to utilize surface-bound becaons.  After beacons are 
specifically linked to a surface, additional beacons or fluorescent material can be rinsed 
away by buffer exchange.  Also, specific chemical linkage of beacons prevents 
detection of fluorescent particles diffusing in solution. 
4.2.1.2. Kinetic Response 
Figure 4.5 shows the kinetic fluorescence response of molecular beacons binding to 
target oligonucleotide as a function of time.  Four concentrations of molecular beacon 
PJAK-2 were loaded into a microplate at volumes at 50 µL of 0 nM, 50 nM, 250 nM and 
1.25 µM.  An additional 50 µL of complementary target oligonucleotide cPJAK was 
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added to each of the wells at concentrations of 0 nM, 100 nM, 500 nM and 2.5 µM.  
Solution in the wells was mixed by pipette and then subsequently scanned in a 
microplate reader, which acquired data at the rate of one measurement per minute for 
70 minutes. 
Over the course of 1 hour, fluorescence counts increased as expected for a 
bimolecular reaction.  At time scales as low as 10 minutes, the target oligonucleotide 
signal is over ten times the background signal (Figure 4.5).  This would indicate that a 
sufficient duration for the molecular beacons to hybridize is 10 minutes, assuming the 
solutions are well-mixed.  Given that the mixing capabilities of our combinatorial 
screening chip are diffusion limited as observed in Chapter 3, this indicates the 
combinatorial screening experiment should allow 1 hour at most for both proper mixing 
and surface hybridization to occur. 
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Figure 4.5  A graph of the kinetic fluorescent response of molecular beacon PJAK-2 (250 nM) to target 
oligonucleotide.  Four wells in a microplate had four concentrations of target oligonucleotide mixed by 
pipette at t=0.  Fluorescence readings were acquired once per minute within each well over the course of 
70 minutes.  Within as little as 10 minutes, a fluorescent signal ten times as large as the background 
baseline can be observed. 
4.2.1.3. Viability of Specifically Linked Molecular Beacons 
To validate the surface modification chemistry of the molecular beacons, an 
experiment was performed within a microplate at the 50-100 µL scale (Figure 4.6).  For 
the three-step preparatory process for glass surface chemistry modification within a 
microplate (discussed in Section 4.4.3.), each step of the surface chemistry 
modifications were included (+) or not included (-).  The three steps were: BSA-biotin 
treatment for 15 minutes, Neutravidin treatment for 15 minutes and BSA for 15 minutes.  
For each well, a fluorescence measurement was made for (i) the 250 nM molecular 
beacons in solution (beacon background in solution), (ii) the glass surface rinsed after 
the 250 nM molecular beacons were loaded (beacons on surface under buffer) and (iii) 
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with target oligonucleotide introduced into the solution (beacons on surface under 
oligomer). 
The first result in Figure 4.6 shows that when all three surface chemistry steps are 
utilized, beacons remain viable and increase in fluorescence when the complementary 
target oligonucleotide is added.  In fact, the surface chemistry modifications indicate that 
Neutravidin alone is sufficient for the molecular beacons to function.  For the four wells 
in which Neutravidin was used, the beacons bound to the bottom surface and were 
active in solution.  For the four wells without Neutravidin, the beacons did not 
specifically link to the surface and were subsequently rinsed out of the chambers.  In the 
remainder of the experiments discussed in this thesis, all steps are generally utilized, as 
the data indicates that the beacons remain chemically viable and able to hybridize to the 
target oligonucleodies when specifically linked to the surface.   
 
 
 
 
 
 
 
 
 
 
Figure 4.6.  A graph of the fluorescence response of PJAK-2 in wells with beacons loaded on the 
surface, rinsed out, and finally treated with complementary target oligonucleotide.  The surface treatment 
including neutravidin appears to be the only sufficient condition for beacon response. 
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4.2.2. Fluorescence Measurements in Flow Cells 
Glass flow cells were constructed using glass coverslips and two-sided tape as 
indicated in Section 4.4.4.  Each flow cell was loaded with BSA-biotin, neutravidin and 
BSA.  Subsequently, molecular beacons at 250 nM concentration were loaded into the 
flow cells and allowed to incubate for 1 hour and then rinsed with TE 50 buffer.  
Fluorescence signals were detected by mounting the flow cells onto a microscope stage 
and fluorescence signals were collected using a charge coupled device (CCD) camera 
(Andor Solis). 
Initial observation of the flow cells showed a high fluorescence background as 
compared to the signal (Figure 4.7).  Although background comparisons of the 
microplate reader showed a signal to noise ratio of 5:1, the signal observed in glass flow 
cells appear to be closer to 1.2:1.  It is possible that loading concentrations are much 
higher in glass based flow cells, due to the surface area to volume ratio typical of 
microfluidic channels.  For the combinatorial experiments for multiplexed virus 
detection, the sensitivity limit for these beacons may need to be lowered in order to 
reduce overcounting and/or overcrowding on a glass surface.   
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Figure 4.7  A graph of PJAK-1 molecular beacon fluorescence response in glass flow cells.  For all three 
tested concentrations (10, 100 and 250 nM), a small but measurable increase in the fluorescence 
response was observed when exposed to the complementary target oligonucleotide in 5:1 ratios. 
 
Figure 4.8  An optical micrograph of the fluid layer of the combinatorial screening chip, described in 
Chapter 3.  Four rows save four 200 pL plugs, sealed by passively closed Actuate-to-Open valves.  After 
these plugs are conserved, four columns perform the same way to create a matrix of 4 x 4 combinations.  
In molecular beacon experiments, the rows are used for different molecular beacons, while the columns 
are used for the virus-representative samples. 
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4.2.3. Multiplexed Viral DNA Detection 
Four molecular beacons containing a HEX and Iowa Black fluorescent and quencher 
pair were obtained from commercial vendor Integrated DNA Technologies (IDT, Table 
4.1).  Each beacon was specifically designed to contain the complementary sequence 
of HIV, HPV and Hepatitis A and Hepatitis B.  Oligomer samples representing 
conserved regions of each of the genetic material of each of the genes of these viruses 
previously identified in literature were used as the representative samples of the target 
viruses [2, 30-32]. 
Table 4.1  A table of sequences for the six molecular beacons and the corresponding target 
oligonucleotides.  # represents a 5' HEX modification, T* represents a biotinylated linker attached to the 
T-base within the stem, and $ represents the Iowa Black quencher attached to the 3' end.  Probe regions 
within the beacons are highlighted in grey, and are complementary to the target oligonucleotides used in 
this studied, prefaced by the letter c. 
 
For the combinatorial mixing chip, four beacons were introduced at 100 pM 
concentrations within each row for each of the viruses using the surface chemistry 
modifications outlined in Section 4.4.  After 30 minutes of incubation, the rows of 
beacon solution were rinsed out with imaging buffer containing 0.04% β-D glucose, 2% 
Name  Sequence    
PJAK-1 #CCACGGTAAGTGTCGTCAACCCGTGG$   
PJAK-2 #GCAGCGTAAGTGTCGTCAACCGC\T*\GC$ 
HIV  #CGTCGCAGTACTCACCAGTCGCCGCCCCTCGCCC\T*\GCGACG$ 
HPV         #CGTCGCAGAAAACCAGTTGTGTCCAAAGGTGTCAGCC\T*\GCGACG$ 
HepA  #CGTCGCAGGGATAGGGTAACAGCGGCGGCC\T*\GCGACG$ 
HepB  #CGTCGCAGGGCTTTCAGTTATATGGATGCC\T*\CGCACG$ 
 
cPJAK GTTGACGACTCTA 
cHIV  GGCGAGGGGCGGCGACTGGTGAGTA 
cHepA CCGCCGCTGTTACCCTATCC 
cHepB CATCCATATAACTGAAAGCC 
cHPV  CTGACACCTTTGGCACAACTGGTTTT 
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catalase and 2% glucose oxidase to minimize photobleaching during the 1-hour 
multiplexed experiment. 
Within each of the columns, target oligonucleotides at 100 nM concentration was 
introduced.  The chip was then mounted onto the fluorescence microscope, and the 
incoming excitation beam was directed to beacons on the surface in TIRF.  For 
background measurements, three regions of interest were selected within each well and 
20 images were collected within each region over 10 seconds at an exposure time of 
500 milliseconds.  After the background was taken, the chip was transported to a 
vacuum source, and the mixing valves were actuated to allow the individual target 
oligonucleotides to diffuse to the beacon loaded compartments.  After allowing 30 
minutes for diffusional mixing, the chip was again mounted onto the fluorescence 
microscope and data was acquired in three different regions of interest. 
As shown in Figure 4.9, only the perfect match beacon-target oligonucleotide 
combination yielded the highest fluorescence response.  Fluorescence signals showed 
standard deviation of ± 100 counts, which represents a statistically significant validation 
of the molecular beacon chip for multiplex virus detection.  Overall, this indicates the 
microfluidic chip is an excellent method for determining the prescence of viral genetic 
material in a series of half-wells on-chip using very low (200 pL) amounts of material. 
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Figure 4.9  Plots of fluorescence measurements for beacons loaded on the combinatorial microfluidic 
mixing and screening chip.  Each beacon is tested against the four oligomer targets, and the strongest 
response from each beacon corresponds to its perfect match.  Negative values (HIV Beacon - HPV 
Target, Hep A Beacon to Hep B target oligonucleotide) may be due to fluorescent particles artificially 
raising background, or due to photobleaching on chip. 
 
Table 4.2.  A table of sequences for the two molecular beacons and the corresponding target 
oligonucleotides.  # represents a 5' HEX modification, T* represents a biotinylated linker attached to the 
T-base within the stem, and $ represents the Iowa Black quencher attached to the 3' end.  Probe regions 
within the beacons are highlighted in grey, and are complementary to the target oligonucleotides used in 
this studied, prefaced by the letter c.  These beacons, modified with 1, 2 or 3 mutations, are underlined to 
emphasize the mutation placement. 
The molecular beacons studied in this work are capable of distinguishing target 
oligonucleotides with single or multi-base changes in sequence.  Virus identification can 
Name  Sequence    
PJAK-1 #CCACGGTTGTGGGTCAACCCCGGTGG$   
PJAK-2 #GCAGCGTAGAGTCGTCCAACCGC\T*\GC$ 
 
cPJAK GGGGTTGACCCACAAG 
cPJAK-O1 GGGGTTCACCCACAAG 
cPJAK-O2 GGGGTTCACCGACAAG 
cPJAK-O3 GGGTTTCACCCGACAAG 
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be challenging, as viral genetic material has the ability to mutate in the replicative 
process [33-36].  Identifying not only the presence of a virus, but also possible mutants 
based on fluorescence detection, would be extremely advantageous for point-of-care 
multiplex screening.  Molecular beacons have previously been studied for mutant 
detection, but were limited to temperature variations to melt apart the mutant-DNA 
mismatches [3].  To determine the sequence specificity of the molecular beacons,  
PJAK-2 molecular beacon was examined at room temperature using four different target 
oligonucleotide samples with a varying number of mutants (Table 4.2).   
The molecular beacon sensitivity to the number of single base mismatches in the 
target sequence was first examined using a microplate reader.  In this experiment, 50 
µL of 250 nM of PJAK-2 was introduced into each of five wells in an optical microplate.  
Within each of these chambers, a corresponding target oligomer with 0, 1, 2, or 3 base 
mismatches was introduced into each chamber at a final concentration of 1.25 µM.  The 
fluorescence response was then measured once per minute for 60 minutes.  Figure 
4.10 demonstrates that the molecular beacon sensitivity is entirely dependent on the 
number of mismatches, and the beacons can clearly distinguish between 1, 2, 3, and no 
base mismatches. 
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Figure 4.10. A plot of the fluorescence response (arbitrary units).  Five wells in a microplate were loaded 
with 250 nM molecular beacons.  Target oligomers with 0, 1, 2, and 3-mismatched bases were introduced 
at a concentration of 1.25 µM into four of the wells at a total volume of 100 µL.  The fluorescence readout 
was sampled every minute for 60 minutes.  During the course of the experiment, the beacon fluorescence 
response was based entirely on number of mismatches. 
 
Figure 4.11.  A plot of the background-subtracted fluorescence response in arbitrary units for the PJAK-2 
beacon against four different target oligonucleotides, segregated by match.  For each of the rows, a 
different concentration of molecular beacon was incubated over the prepared glass surface of the 
combinatorial device.  (1 = 125 nM loading of molecular beacon, 2 = 250 nM loading, 3 = 500 nM loading, 
and 4 = 1000 nM loading).  For all cases except the perfect match at the two highest concentrations of 
beacon loading, no well indicated an appreciable increase in signal over the background concentration. 
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The combinatorial screening chip was then employed to study mutant detection 
using four different concentrations of the PJAK-2 molecular beacon.  For each of four 
rows (1-4), PJAK-2 molecular beacons were incubated at concentrations of 125 nM, 
250 nM, 500 nM and 1000 nM for 30 minutes in each row, respectively.  Along the 
vertical wells, 1.25 µM of cPJAK, cPJAK-O1, cPJAK-O2, and cPJAK-O3 were 
introduced representing the match, 1-mismatch, 2-mismatch and 3-mismatch targets.  
Surfaces were prepared using the method discussed in Section 4.4.3.  The purpose of 
this experiment was to observe if the results observed in the microplate reader could be 
replicated at the microscale. 
Figure 4.11 demonstrates that only the high concentration trials of 500 nM and 1000 
nM PJAK-2 beacons were able to reliably indicate the presence of the matching target 
oligomer cPJAK.  Mutant detection was not possible at the loading concentrations 
attempted in this work.  It is possible that the fluorescent signal would be stronger using 
imaging buffer to reduce fluorescence variation and photobleaching, but this was not 
done in this work. 
4.3. Conclusions 
The combinatorial screening and mixing chip was validated with the molecular 
beacon experiment for multiplex detection on a 4 x 4 sample for 16 combinations of 4 
matches and 12 non-matches.  At the low concentration of 100 pM, beacons loaded in 
each well served as a positive indicator of the presence of a target oligonucleotide 
containing the conserved sequence of viral DNA.  In addition, these experiments utilized 
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far less molecular beacons than those in previous studies.  As a proof-of-principle 
experiment, molecular beacons function effectively within the combinatorial chip and 
serve as a viable means of target oligonucleotide detection. 
While this work attempted to incorporate mutant detection into the overall scheme of 
device operation and initial studies using microplate readers indicated the sensitivity of 
molecular beacons to single base mutant was possible, this level of discrimination was 
not observed at the microfluidic scale.  It is possible that photobleaching could have 
occurred during the experiment, and future work should utilize an imaging buffer as 
outlined in the previous example in order to determine if the signal is appreciably strong. 
One possible direction would be to begin studying whole viral genomic DNA in a 
PCR amplification reaction in order to increase the signal to noise ratio.  There are a 
number of hurdles associated to working with live viruses including biosafety protocols 
and mutations, which would have to be circumvented in order to pursue this as a point-
of-care option.  Given the scale of this combinatorial chip, further study into increasing 
the shelf-life of molecular beacons and storage conditions to maintain fidelity of the 
beacon operation.  Also, expanding the chip to include a larger combination of screens 
with increased combinations would be an impressive benefit for large scale 
combinatorics and screening techniques of patient samples.  If the molecular beacon 
work could be expanded to include fluorescence-based sensitivity to the presence of 
mutants, it is expected that these microfluidic chips could achieve a higher sensitivity 
using fewer amounts of molecular beacons to viruses and virus mutants.  In the current 
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state, additional work is needed to determine if the fluorescence signal is strong enough 
at the microscale for these combinatorial screening systems. 
4.4. Materials and Methods 
4.4.1. Device Fabrication 
Devices were prepared in Freehand MX using multilayer soft lithography as 
discussed in previous work [37, 38].  For designing the combinatorial screening chip, 
the fluid layer was composed of a network of four horizontal channels intersecting with 
four vertical channels, each 75 µm in width.  At the end of these channels, 600 µm 
circular regions were designed to make the inlet/outlet ports.  The half-well chambers 
were composed of 250 µm circles connected to 150 µm lines forming the U-shaped 
half-wells.  All gaps for these microchannels were 40 µm in width and placed at an 
angle whenever possible to reduce the pressure required to open the valves.   
The control layer was also designed using Freehand MX.  Square valves were 
placed throughout the device to cover each gap of the fluid layer, measuring 248 µm x 
236 µm for the valves over horizontal flowing microchannels, 198 µm x 495 µm for the 
valves over the vertical flowing channels, and 292 µm x 347 µm for the mixing valves.  
These valves were connected via 49 µm microchannel runner lines to three input 
circles, 600 µm in diameter.  In order to connect the three types of valves to only three 
valve inputs, the mixing and the vertical movement valves were interdigitated across the 
chip, with the horizontal flowing valves snaking back and forth throughout the design.  
Because the horizontal valves travel across the farthest length, these valves were the 
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most susceptible to vacuum leakage and were often the first to malfunction if the chip 
showed signs of failure. 
These designs were then replicated onto a transparency mask using the laser 
printing services of the University of Illinois Print Shop.  Two silicon wafers were first 
cleaned using acetone and then isopropanol, followed by drying under nitrogen and 
heated to 110°C to remove any water that might condensate onto the silicon wafers 
during drying for 10 minutes.  At the end of this drying time, the wafers were placed 
inside a spin coater.  Two milliliters of SU-8 25 were placed on the center of the wafer 
for spin coating treatment.  The program run by the spin coater ramped up to 2000 
RPMs over 10 seconds, and then held at 2000 RPMs for 30 additional seconds.  After 
this, it ramped back down to 0 RPMs in 10 seconds.  This procedure yielded a thin layer 
of photoresist 25 µm in height. 
After coating, the wafer was then placed onto a hot plate preset at 65°C for 4 
minutes.  The wafer was then transferred to the second hot plate at 95°C for 8 minutes.  
The wafer was then allowed to cool for 1 minute, and then placed in a collimated UV 
light source and exposed for 20 seconds at 11 µW/cm2.  The wafer was then developed 
in PGMEA (propylene glycol methyl ether acetate) for 5 minutes, taking care to rinse 
with ispropanol.  If any white residue remained on the surface of the silicon wafer, it was 
placed back in the PGMEA and developed further.  When the silicon wafer could be 
rinsed with isopropanol and no white residue remained, the wafer was subsequently 
dried under nitrogen and stored in a petri dish.  At this point, the silicon wafers with 
photoresist designs are called masters. 
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To prepare these masters for device production, they were first placed in a 
dessicator with silanizing agent for four hours.  PDMS base and crosslinking agents 
were mixed in a 5:1 ratio for the control layer, and a 15:1 ratio for the fluid layer.  This 
difference in crosslinker ratio allows for a tighter bond between the two layers after 
partially curing the layers separately.  The very first time a control master is used for 
device fabrication, 30 g of PDMS mixture will be required to pour into a standard size 
petri dish, which will yield a device with a thickness around 3-5 mm.  Subsequent 
devices made with the control master will only need 15 g of PDMS, due to the ring of 
unused PDMS that can be used as a placeholder from earlier device fabrication 
attempts.  For the fluid layer, only 10 g of PDMS mixture is needed.  1-2 mL of PDMS is 
poured onto the surface of a fluid layer master, which is then placed inside a spin coater 
for the same program outlined above at 2000 RPMs.  This will yield a thickness of 45 
µm PDMS for microchannels that are 25 µm in height. 
Both layers are placed inside an oven set to 65°C for 30 minutes, and are then 
checked for tackiness.  If the PDMS on the fluid layer master is solid but still sticky, the 
device can be aligned.  The control layer is cut out using a razor or scalpel, and holes 
are punched to connect to the valves in the control layer.  Given that the height of the 
control channels are only 25 µm, this pattern can be very challenging to see.  The use 
of additional and direct lighting is absolutely required, since any failed punch will destroy 
the utility of the device.  When all holes to the control layer valves have been punched, 
the fluid layer master is placed onto a vacuum-chuck mount under a microscope.  
Alignment requires careful placement of the control layer above the fluid layer, while 
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making sure valves align properly to gaps in the fluid layer.  This can be done by hand, 
or using a mechanical alignment system for careful iterative adjustment.  If only a 
certain portion of the valves are aligned, the device can be lifted at a corner, causing the 
design to be stretched or contorted to fit all valves onto the fluid layer. 
Once the valves are aligned, the device is placed into the oven at 65°C for 1 hour to 
fully cure the layers together to form an irreversible seal.  After curing, the device is cut 
from the fluid layer master using a scalpel or razor, and holes are punched to provide 
inlets for the fluid layer microchannels exposed on the bottom of the device.  If the 
device is not to be used immediately in an experiment, it is placed onto a pre-cleaned 
glass slide to ensure that no dust particles adhere to the clean microchannel surface 
underneath. 
4.4.2. Solution Preparation 
All DNA materials are ordered lyophilized from Integrated DNA Technologies.  Upon 
receipt of the molecular beacon or oligonucleotide samples, the sample is dissolved in 
TE 50 buffer (10 mM Tris/HCl buffer [pH = 8.0], 1 mM EDTA, 50 mM NaCl) to a 
concentration of 100 or 200 µM.  These stock solutions are stored in a -20°C freezer for 
long term storage.  Neutravidin and BSA-Biotin are purchased lyophilized from Sigma 
Aldrich.  These 1g pellets are dissolved in TE 50 buffer, and freeze dried in liquid 
nitrogen in 50 µL aliquots at a concentration of 5g/mL and 10 g/mL respectively.  These 
aliquots are stored in a -80°C freezer.  Before each experiment, an aliquot each of the 
Neutravidin and BSA-biotin tubes are removed from the freezer and thawed by hand, 
followed by the addition of 450 µL of TE 50 buffer.  For the surface chemistry protocol, 
85 
 
the final concentrations of the BSA-biotin and Neutravidin aliquots are 1.0 g/mL and 0.5 
g/mL, respectively.  
4.4.3. Surface Chemistry Protocol 
For all experiments, a glass slide was cleaned with acetone, isopropyl alcohol and 
millipore water.  The slide was then dried under argon, and either built into a glass flow 
cell or integrated to a PDMS-based microfluidic screening chip.  BSA-biotin (1 mg/mL) 
in TE 50 buffer was loaded for 15 minutes into the microchannels of the device.  These 
were then rinsed with TE 50 buffer.  Neutravidin (0.5 mg/mL) in TE 50 buffer was loaded 
for 15 minutes into the microchannels of the device and subsequently rinsed with TE 50 
buffer.  Molecular beacons, in concentrations varying from 100 pM to 250 nM, were 
introduced into the chip and allowed to incubate between 15 and 60 minutes, depending 
on the experiment.  After loading, extra beacons were rinsed out with TE 50 buffer or 
imaging buffer. 
4.4.4. Glass flow cells 
Glass slides were cleaned using acetone, isopropanol and millipore water.  They 
were then dried under nitrogen.  Double sided tape was placed on one glass slide, with 
excess tape cut off with a razor.  The second glass slide was then mounted on top of 
the tape, creating an open microchannel in a glass-based flow cell. 
4.4.5. Microscope Setup 
The fluorescence microscope used a green laser (538 nm, 625 µW) focused to the 
back of a 100x objective on an inverted microscope.  The focal point of an incoming 
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lens was adjusted to focus the beam at the incident angle in the microfluidic device/flow 
cell.  After passing through a filter, fluorescence was taken on an Andor Solis camera.  
Data collection was done for 500 millisecond intervals for a kinetic run between 20 and 
100 pictures.  Three spots were taken over the 20 or 100 picture kinetic length, and all 
pictures were averaged together over a region of interest centered on the Gaussian 
excitation beam.   
4.4.6. Multiplex Screening Experiment 
For the combinatorial multiplex screening experiment, the devices were assembled 
as above in Section 4.4.1.  After the device is finished, it is mounted onto a cleaned 
glass coverslip and treated to the surface chemistry steps in Section 4.4.3.  For the 
multiplex screening experiment, four different molecular beacons were introduced within 
each row of the combinatorial screening chip at a concentration of 250 µM.  These 
beacons were allowed to incubate for 30 minutes, and subsequently rinsed with TE 50 
buffer.  The device and coverslip were then mounted onto the fluorescence microscope 
outlined in Section 4.4.5.  Within each well with rinsed beacons, three regions of interest 
were identified within the confines of the horizontal half-wells using brightfield 
illumination.  Just before data collection, the shutter for the excitation laser was opened, 
impinging on combinatorial device at the incident angle in TIRF.  100 images (500 msec 
exposure) were taken, recording an absolute value of the fluorescence collection on an 
Andor Solis camera. 
At the conclusion of the last image, the file was saved as a stack in TIFF format.  
After all wells had three regions of interest studied, the device was then transported to a 
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microscope and the subsequent target oligonucleotides were introduced into the vertical 
chambers, using the vertical valve operation under vacuum [39].  After all four target 
oligonucleotides were introduced into the vertical half-wells, the mixing valve was 
opened and closed over 30 minutes to force the oligonucleotide solutions to mix across 
each of the surfaces with specifically linked molecular beacons in a combinatorial, but 
discrete fashion.  The valves remained open for 30 minutes after this. 
The valves were then allowed to relax back to rest state, isolating all half-wells 
throughout the device.  The device was then transported back to the fluorescence 
microscope, and half-well chambers were once again located in brightfield lumination.  
Within each well, three new regions of interest were located away from previously 
identified regions of interest.  For each of these new regions of interest, fluorescence 
was collected by the camera for 100 images.   
For analysis, the averaged values of the spots were performed using ImageJ across 
a selected region on all stacks, and these final values were averaged to determine the 
count value for a particular well.  When plotting the average value of a stack over each 
of the images within that stack (a function of time), the fluorescence detection was 
observed to generally decrease as a function a time, a result of the photobleaching 
occurring during this experiment. 
4.4.7. Multiplex Screening Experiment with Imaging Buffer 
As a method to discourage photobleaching and introduce lower concentrations of 
molecular beacons, an oxygen scavenger was used in the buffer to reduce the amount 
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of photobleaching during the experiment.  2% wt/v glucose oxidase, 2% wt/v catalase 
and 0.04 % wt/v glucose were dissolved in TE 50 buffer and used for the imaging buffer. 
For these experiments, surface chemistry treatment remained the same.  However, 
four different molecular beacons at concentrations of 100 pM were loaded for 15 
minutes in order to reduce the amount of beacon loading on the surface.  After these 
beacons were loaded, the remaining solution was rinsed out using imaging buffer.  At 
these concentrations, the oxygen scavenger in the imaging buffer no longer functions 
after 1 hour has passed.  To accommodate this, the four target oligonucleotides were 
introduced into the vertical half-wells all on chip.  Three regions of interest were 
selected within each well, but was limited to 20 pictures because of time constraints.  
After all pictures were taken, the device was transported to a microscope and mixing 
valves were activated by vacuum.  Oligonucleotides were allowed 20 minutes to mix 
and hybridize to the molecular beacons.  The device was then transported back to the 
fluorescence microscope and fluorescence data was again collected in the same 
fashion.  The image analysis protocol remained the same. 
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Chapter 5 
Conclusions and Future Directions 
5.1. Conclusions  
Screening can be a time-consuming process when hundreds or thousands of 
experiments need to be performed, but these experiments can be performed at the 
microscale using less reagents  [1-4].  As observed in these studies, by downscaling the 
experiments, we can repeat experiments at the benchtop scale with the same accuracy 
and using far less reagent.  Techniques such as multilayer soft lithography [5-8] also 
allow for smaller ‘well plates’ to be created afford a greater degree of control over the 
experiment and screening processes.  Such microscale approaches can provide for a 
framework for a higher degree of complexity at these small scales.  The microfluidic 
screening components presented here not only exploit, but also depend upon the 
physical characteristics of the microscale in order to operate.    
As deduced in the design rules discovered for valve operation, there is a strong 
affinity between the PDMS and glass.  In fact, valve failure is almost entirely influenced 
by the strong adhesive forces between these two materials.  Valve actuation behavior 
could be tuned, either by changing parameters such as microchannel width or geometry 
to change the opening pressure, or by changing the thickness of the PDMS layer to 
change the closing pressure of the device.  In chapter 2 these valves were observed to 
be dependent on the width of the fluidic microchannel, which could change the pressure 
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requirements by as much as 100-200 torr.  By increasing the thickness of the fluid 
channel thickness, the valves were less likely to open, due to the increase in membrane 
stiffness.  When the geometry of the valves was changed, weak points were introduced 
on the chip, which reduced the required pressure to separate the PDMS from the glass 
surface needed to operate the valve.  These experiments provided a deeper 
understanding of the factors that determine valve operation and from this design rules 
were derived to aid the development of high density systems that are required for high 
throughput screening processes. 
In Chapter 3, the AtO valves designed and studied in chapter 2 were employed in a 
combinatorial screening chip.  At the microscale, surface to volume ratios are typically 
high, and this ratio was exploited using a surface-based approach to sensing the 
combinatorial reactions performed on chip.  For sensing purposes, the combinatorial 
chip was integrated with a patterned photonic crystal biosensor, which identified 
changes in binding within each half-well of a 4 x 4 combinatorial mixing chip [9].  
Sixteen compartments, controlled by three separate valves, were designed at a reaction 
density of 1/mm2 for all fill lines and valves.  Within these very small densities, the 
valves coordinate filling in the horizontal direction, the vertical direction and mixing.  For 
a given half-well, 200 pL of reactant A can mix with 200 pL of reactant B, and this can 
be done all in concert to provide A1B1 to A4B4 products.  This chip was validated with a 
proof-of-principle protein-antibody assay, demonstrating the combinatorial mixing 
capabilities of the chip.   
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For DNA-based sensing of viruses, the combinatorial mixing chip was employed with 
surface-bound molecular beacons as described in Chapter 4.  The combinatorial nature 
of the microfluidic chip developed in Chapter 3 was employed with little alteration for this 
purpose.  Since the device uses AtO valves with a reversible seal, the bottom layer of 
the device was interchanged from the photonic crystal biosensor to a molecular beacon 
patterned cover slip.  These molecular beacons were observed to have a high 
background in glass-based flow cell studies, which was overcome by employing 
analysis using TIRF microscopy in which only the area just above the surface was 
excited.  The 4x4 combinatorial chip tested four molecular beacons against four 
different virus-representative oligomer samples from conserved regions within the 
genes of each virus [10-13].  The surface-based approach of this analysis coupled to 
the microscopy technique of TIR meant that these studies could be performed using 
100 pM of molecular beacon samples at very small volumes, orders of magnitude less 
than previously published sensitivity studies [14, 15]. 
In both screening techniques, the physics of the microscale was exploited to 
duplicate bench scale experiments at the microscale, using far less material while 
maintaining the fidelity of the results.  For drug discovery, this would reduce the amount 
of potentially precious reagent used for testing against disease-related proteins.  For 
virus detection, the combinatorial chip can exploit the surface-based approach of 
mounted molecular beacons and TIRF to discover the presence of a particular DNA 
sequence.  These results were validated against what was expected at larger scales, 
but both were performed with far less reagent than what was used in the literature. 
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5.2. Future Directions 
The next step for this work in microfluidic screening would be to apply the system to 
real-world problems, tackling the next set of variables that arise with more complex 
biological systems.   
The design rules elucidated in Chapter 2 for the actuate-to-open valves provide a 
greater framework for future microfluidic devices.  With this knowledge, the devices 
made here could be scaled out with a greater confidence of operation.  A typical 
problem in valve actuation lies in the gas permeability of PDMS.  As control channel 
lines become longer and longer over a large array of reaction sites, the pressure drop 
becomes more and more significant.  With these design rules derived in this work, it is 
now easier to scale these devices out to create large arrays typical of 8 x 12 microplates 
studies used in conventional screening studies. 
One future direction for the valves would be in new materials.  The valves presented 
here are fabricated using PDMS, which is an elastomeric polymer that is incompatible 
with many organic solvents.  PDMS is an ideal polymer for research purposes.  Small 
changes in device design can be made within a few days.  Unfortunately, this attractive 
rapid device development characteristic comes with issues such as poor shelf life and 
the aforementioned solvent incompatibility.  For the medical devices discussed above, 
fluidic routes can be studied using PDMS-based chips, but for something that would 
need to survive on a shelf in a hospital for months at a time, a new polymer must be 
developed.  Being able to fabricate these valves in a more solvent-compatible polymer 
would open up a vast array of possible chemical synthesis routes and applications.   
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The screening experiments performed using the photonic crystal biosensor were 
validated with a proof-of-principle experiment, but other routes exist for this kind of 
integrated chip.  The protein-antibody experiment was good for demonstrative 
purposes, and now that the fluidics are established and validated at the microscale, the 
new frontier would be to examine new protein - combinatorial library interactions.  
Previous work in click chemistry has yielded several small molecule libraries of 
heterocyclic compounds made with precious reagent with well studied examples of 
interactions with cancer-related proteins.  Validating that screen at the microscale would 
be another big step forward in advancing high throughput combinatorial technology for 
drug discovery. 
The next steps for the multiplex virus identification chip would include working with 
actual viruses to determine how other biological components might contribute to fouling 
of the surface-beacon controlled surface.  In microplate studies, molecular beacons 
were able to discover virus quantities as low as 1 active virus unit using epifluorescence 
microscopy.  Validating these same results at the microscale using real components 
such as human blood would advance the field of diagnostics.  Reducing the 
identification threshold could lead to hospital-based diagnostic studies that use very 
small amounts of blood to achieve accurate results in point-of-care tests.  This kind of 
patient care advancement is constantly sought after for microscale-based devices. 
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